Health ministry decides against including Itolizumab in clinical management protocols for COVID-19
PTI, Jul 26, 2020, 9:17 PM IST
New Delhi: The National Task Force on COVID-19 has decided against including Itolizumab drug in clinical management protocols for treating the disease even though the DCGI has approved its “restricted emergency use” in infected patients, official sources said.
Considering the unmet medical needs in COVID-19, Itolizumab, an already approved drug of Biocon, used for treating psoriasis — a skin condition — was approved for “restricted emergency use” in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.
The permission to market the drug was granted for the treatment of cytokine release syndrome in ”moderate” to ”severe” Acute Respiratory Distress Syndrome patients due to COVID-19.
“The issue of including the drug in the clinical protocols was discussed in a meeting held on Friday. A majority of the members of the task force opined that there was not enough evidence currently to get the drug included in the clinical management protocols for COVID-19,” said an official source.
A domestic biopharmaceutical company, Biocon, has been manufacturing and marketing Itolizumab, a monoclonal antibody, for the treatment of patients with moderate to severe chronic plaque psoriasis since 2013, under the brand name ALZUMAb, the Union health ministry had earlier said.
However, a Biocon spokesperson said, “The National Covid Task Force needs to see more evidence and we will provide them large real-world data to enable the committee to reconsider its decision on inclusion of Itolizumab in the protocol.”
“Nearly 1,000 patients have used the drug across the country with good outcome data,” the company spokesperson said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Seven more states to administer Covaxin from next week: Health Ministry
Immune system of recovered COVID-19 patients may evolve to fight SARS-CoV-2 variants says study
COVID-19: 902 new cases in Karnataka, 3 deaths
150 People infected with UK variant of Covid-19 in India, says Govt
COVID-19 vaccine for airport staff in Karnataka
MUST WATCH
The lorry driver’s disaster on the national highway: Hundreds of lives saved | Udayavani
Compol appeals people to share info regarding any untoward developments through Whatsapp
Mangaluru: Police arrest nine students for alleged ragging
Remembering Netaji Subhas Chandra Bose | Asha Raghuvamshi
Inter-state Ganja smuggling racket busted: 7 held, 44.630 kgs of Marijuana seized
Latest Additions
My statement on illegal quarrying has been misunderstood: BSY
National Girl Child Day: PM Modi hails accomplishments of nation’s daughters in various fields
Motorists move in darkness due to non-operating lightposts on BC Road-Panemangalore h’way
India to display key military assets on R-Day; contingent of Bangladesh excited to march down Rajpath
Aviation sector workers be vaccinated on priority after health workers: MoCA to MoHFW